BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/30/2025 8:30:55 AM | Browse: 9 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 115722
Country China
Category Oncology
Manuscript Type Review
Article Title Microbiota-driven immunometabolic regulation in colorectal cancer: Mechanisms and therapeutic opportunities
Manuscript Source Invited Manuscript
All Author List Wen-Yu Luan, Shu-Ping Zhang, Kai-Zhen Xu, Yu-Hui Shang, Wen-Jian Hu, Hui Sun and Yan-Dong Miao
Funding Agency and Grant Number
Funding Agency Grant Number
Shandong Province Medical and Health Science and Technology Development Plan Project 202203030713
Yantai Science and Technology Program 2024YD005
Yantai Science and Technology Program 2024YD007
Yantai Science and Technology Program 2024YD010
Science and Technology Program of Yantai Affiliated Hospital of Binzhou Medical University YTFY2022KYQD06
Corresponding Author Yan-Dong Miao, Cancer Center, Yantai Affiliated Hospital of Binzhou Medical University, The 2nd Medical College of Binzhou Medical University, No. 717 Jinbu Street, Muping District, Yantai 264100, Shandong Province, China. miaoyd_22@bzmc.edu.cn
Key Words Colorectal cancer; Gut microbiota; Immunometabolism; Tumor microenvironment; Metabolic reprogramming
Core Tip The treatment of colorectal cancer (CRC) faces challenges of drug resistance mediated by the tumor microenvironment (TME). This review proposes that the gut microbiota is a core regulator in reshaping CRC immune metabolism and TME. We have established an integrated framework of the “microbiota-immune metabolism-TME” axis, systematically elaborating on the mechanisms of CRC occurrence, development, and treatment resistance from the micro level to the macro level. This perspective provides new ideas for deconstructing complexities such as clinical drug resistance. Based on this, we further explore translational strategies targeting the microbiota to reverse immunosuppression, enhance the efficacy of radiotherapy, chemotherapy, and immunotherapy, offering innovative theoretical basis and intervention prospects for the precise treatment of CRC.
Citation Luan WY, Zhang SP, Xu KZ, Shang YH, Hu WJ, Sun H, Miao YD. Microbiota-driven immunometabolic regulation in colorectal cancer: Mechanisms and therapeutic opportunities. World J Gastrointest Oncol 2025; In press
Received
2025-10-24 02:49
Peer-Review Started
2025-10-24 02:50
First Decision by Editorial Office Director
2025-11-18 10:59
Return for Revision
2025-11-20 06:46
Revised
2025-12-09 07:19
Publication Fee Transferred
Second Decision by Editor
2025-12-30 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-30 08:30
Articles in Press
2025-12-30 08:30
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com